Maternal Use of Specific Antidepressant Medications During Early Pregnancy and the Risk of Selected Birth Defects

Aug 06, 2020

Research found some associations between maternal antidepressant use and specific birth defects. Venlafaxine was associated with the highest number of defects, which needs confirmation given the limited literature on venlafaxine use during pregnancy and risk for birth defects. The results suggest confounding by underlying conditions should be considered when assessing risk. Jama Network


Other news

Cookies help us deliver our services. By using our services, you agree to our use of cookies. What are cookies?